T1	Outcomes 709 792	scores of erythema, scaling/hypertrophy and induration as well as pain and itching;
T2	Outcomes 863 893	scored by patients' assessment
T3	Outcomes 972 1036	scaling/hypertrophy, pain, itching and global patient assessment